Centric Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.87M | Buy |
24,023
+2,736
| +13% | +$327K | 0.68% | 52 |
|
2025
Q1 | $2.39M | Buy |
21,287
+5,396
| +34% | +$605K | 0.63% | 57 |
|
2024
Q4 | $1.47M | Buy |
+15,891
| New | +$1.47M | 0.4% | 71 |
|
2020
Q4 | – | Sell |
-3,253
| Closed | -$200K | – | 196 |
|
2020
Q3 | $200K | Sell |
3,253
-12,023
| -79% | -$739K | 0.15% | 110 |
|
2020
Q2 | $1.18M | Buy |
15,276
+12,023
| +370% | +$925K | 0.62% | 44 |
|
2020
Q1 | $200K | Sell |
3,253
-7,555
| -70% | -$464K | 0.15% | 110 |
|
2019
Q4 | $702K | Buy |
10,808
+7,555
| +232% | +$491K | 0.56% | 44 |
|
2019
Q3 | $200K | Buy |
3,253
+50
| +2% | +$3.07K | 0.15% | 110 |
|
2019
Q2 | $216K | Buy |
+3,203
| New | +$216K | 0.19% | 93 |
|